Compare GODAVARI DRU with Glenmark Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GODAVARI DRU vs GLENMARK PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GODAVARI DRU GLENMARK PHARMA GODAVARI DRU/
GLENMARK PHARMA
 
P/E (TTM) x 8.4 14.1 59.9% View Chart
P/BV x 1.7 2.1 80.2% View Chart
Dividend Yield % 0.0 0.5 -  

Financials

 GODAVARI DRU   GLENMARK PHARMA
EQUITY SHARE DATA
    GODAVARI DRU
Mar-21
GLENMARK PHARMA
Mar-21
GODAVARI DRU/
GLENMARK PHARMA
5-Yr Chart
Click to enlarge
High Rs60573 10.5%   
Low Rs10195 4.9%   
Sales per share (Unadj.) Rs162.9387.8 42.0%  
Earnings per share (Unadj.) Rs5.534.4 15.9%  
Cash flow per share (Unadj.) Rs7.150.1 14.2%  
Dividends per share (Unadj.) Rs02.50 0.0%  
Avg Dividend yield %00.7 0.0%  
Book value per share (Unadj.) Rs32.4249.6 13.0%  
Shares outstanding (eoy) m7.53282.17 2.7%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x0.21.0 21.5%   
Avg P/E ratio x6.311.2 56.8%  
P/CF ratio (eoy) x4.97.7 63.8%  
Price / Book Value ratio x1.11.5 69.8%  
Dividend payout %07.3 0.0%   
Avg Mkt Cap Rs m262108,353 0.2%   
No. of employees `000NANA-   
Total wages/salary Rs m3923,437 0.2%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m1,227109,439 1.1%  
Other income Rs m4502 0.8%   
Total revenues Rs m1,231109,941 1.1%   
Gross profit Rs m9821,289 0.5%  
Depreciation Rs m124,436 0.3%   
Interest Rs m333,531 0.9%   
Profit before tax Rs m5713,825 0.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m164,124 0.4%   
Profit after tax Rs m419,701 0.4%  
Gross profit margin %8.019.5 41.2%  
Effective tax rate %27.729.8 92.7%   
Net profit margin %3.48.9 38.0%  
BALANCE SHEET DATA
Current assets Rs m67673,596 0.9%   
Current liabilities Rs m50542,010 1.2%   
Net working cap to sales %13.928.9 48.3%  
Current ratio x1.31.8 76.4%  
Inventory Days Days17 15.0%  
Debtors Days Days134,256,17786 156,507,237.7%  
Net fixed assets Rs m23567,093 0.4%   
Share capital Rs m75282 26.7%   
"Free" reserves Rs m16970,148 0.2%   
Net worth Rs m24470,430 0.3%   
Long term debt Rs m14538,888 0.4%   
Total assets Rs m911140,689 0.6%  
Interest coverage x2.74.9 55.3%   
Debt to equity ratio x0.60.6 107.6%  
Sales to assets ratio x1.30.8 173.0%   
Return on assets %8.29.4 86.9%  
Return on equity %16.913.8 122.9%  
Return on capital %23.215.9 146.3%  
Exports to sales %1.00-   
Imports to sales %62.10-   
Exports (fob) Rs m12NA-   
Imports (cif) Rs m761NA-   
Fx inflow Rs m1235,753 0.0%   
Fx outflow Rs m76112,023 6.3%   
Net fx Rs m-74923,729 -3.2%   
CASH FLOW
From Operations Rs m1311,312 0.1%  
From Investments Rs m-13-6,752 0.2%  
From Financial Activity Rs m1-4,418 -0.0%  
Net Cashflow Rs m2278 0.8%  

Share Holding

Indian Promoters % 56.1 46.7 120.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.5 35.0 1.4%  
FIIs % 0.0 25.9 -  
ADR/GDR % 0.0 0.0 -  
Free float % 43.9 53.4 82.2%  
Shareholders   5,394 329,870 1.6%  
Pledged promoter(s) holding % 14.5 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GODAVARI DRU With:   AURO LAB.  ASTRAZENECA PHARMA  SMS PHARMA  CHANDRA BHAGAT PHARMA  ADVANCED ENZYME TECHNOLOGIES  



Today's Market

Bloodbath on Dalal Street: 6 Reasons Why Sensex Slumped 1,688 Points Today(Closing)

Indian share markets witnessed negative trading activity throughout the day today and ended deep in the red.

Related Views on News

GLENMARK PHARMA 2020-21 Annual Report Analysis (Annual Result Update)

Sep 6, 2021 | Updated on Sep 6, 2021

Here's an analysis of the annual report of GLENMARK PHARMA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of GLENMARK PHARMA. Also includes updates on the valuation of GLENMARK PHARMA.

GLENMARK PHARMA Announces Quarterly Results (1QFY22); Net Profit Up 20.7% (Quarterly Result Update)

Aug 16, 2021 | Updated on Aug 16, 2021

For the quarter ended June 2021, GLENMARK PHARMA has posted a net profit of Rs 3 bn (up 20.7% YoY). Sales on the other hand came in at Rs 30 bn (up 26.4% YoY). Read on for a complete analysis of GLENMARK PHARMA's quarterly results.

GLENMARK PHARMA Announces Quarterly Results (1QFY21); Net Profit Up 132.5% (Quarterly Result Update)

Sep 1, 2020 | Updated on Sep 1, 2020

For the quarter ended June 2020, GLENMARK PHARMA has posted a net profit of Rs 3 bn (up 132.5% YoY). Sales on the other hand came in at Rs 23 bn (up 0.9% YoY). Read on for a complete analysis of GLENMARK PHARMA's quarterly results.

GLENMARK PHARMA Announces Quarterly Results (3QFY20); Net Profit Up 64.0% (Quarterly Result Update)

Feb 19, 2020 | Updated on Feb 19, 2020

For the quarter ended December 2019, GLENMARK PHARMA has posted a net profit of Rs 2 bn (up 64.0% YoY). Sales on the other hand came in at Rs 27 bn (up 7.1% YoY). Read on for a complete analysis of GLENMARK PHARMA's quarterly results.

GLENMARK PHARMA Announces Quarterly Results (1QFY21); Net Profit Up 132.5% (Quarterly Result Update)

Sep 1, 2020 | Updated on Sep 1, 2020

For the quarter ended June 2020, GLENMARK PHARMA has posted a net profit of Rs 3 bn (up 132.5% YoY). Sales on the other hand came in at Rs 23 bn (up 0.9% YoY). Read on for a complete analysis of GLENMARK PHARMA's quarterly results.

More Views on News

Most Popular

Infosys vs TCS: Which is Better?(Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake(Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

How to Hit Rs 100 Crore Wealth in Your Lifetime(Equitymaster Wealth)

Nov 15, 2021

This is how you can achieve the ambitious goal of a net worth of Rs 100 crore.

Don't Sell these Stocks if the Market Falls(Profit Hunter)

Nov 17, 2021

These are the 3 types of stocks that you should not sell in a market crash.

MobiKwik IPO Opens for Subscription Soon. Key Things to Know Before Subscribing.(Views On News)

Nov 20, 2021

The Rs 19 bn issue is set to hit the market soon.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

GODAVARI DRU SHARE PRICE


Nov 26, 2021 (Close)

TRACK GODAVARI DRU

  • Track your investment in GODAVARI DRU with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

GODAVARI DRU - LUPIN COMPARISON

COMPARE GODAVARI DRU WITH

MARKET STATS